Protein Glycation by Glyoxal Promotes Amyloid Formation by Islet Amyloid Polypeptide

Yi Hsuan Hsu, Yun-Wen Chen, Meng Hsin Wu, Ling Hsien Tu

Research output: Contribution to journalArticle

Abstract

Protein glycation, also known as nonenzymatic glycosylation, is a spontaneous post-translational modification that would change the structure and stability of proteins or hormone peptides. Recent studies have indicated that glycation plays a role in type 2 diabetes (T2D) and neurodegenerative diseases. Over the last two decades, many types of advanced glycation end products (AGEs), formed through the reactions of an amino group of proteins with reducing sugars, have been identified and detected in vivo. However, the effect of glycation on protein aggregation has not been fully investigated. In this study, we aim to elucidate the impact of protein glycation on islet amyloid polypeptide (IAPP, also known as amylin) aggregation, which was strongly associated with T2D. We chemically synthesized glycated IAPP (AGE-IAPP) to mimic the consequence of this hormone peptide in a hyperglycemia (high blood sugar) environment. Our data revealed that AGE-IAPP formed amyloid faster than normal IAPP, and higher-molecular-weight AGE-IAPP oligomers were also observed in the early stage of aggregation. Circular dichroism spectra also indicated that AGE-IAPP exhibited faster conformational changes from random coil to its β-sheet fibrillar states. Moreover, AGE-IAPP can induce normal IAPP to expedite its aggregation process, and its fibrils can also act as templates to promote IAPP aggregation. AGE-IAPP, like normal IAPP, is capable of interacting with synthetic membranes and also exhibits cytotoxicity. Our studies demonstrated that glycation modification of IAPP promotes the amyloidogenic properties of IAPP, and it may play a role in accumulating additional amyloid during T2D progression.

Original languageEnglish
Pages (from-to)2304-2313
Number of pages10
JournalBiophysical Journal
Volume116
Issue number12
DOIs
Publication statusPublished - 2019 Jun 18

Fingerprint

Glyoxal
Islet Amyloid Polypeptide
Amyloid
Type 2 Diabetes Mellitus
Peptide Hormones
Proteins
Advanced Glycosylation End Products
Protein Stability
Post Translational Protein Processing
Circular Dichroism
Glycosylation
Hyperglycemia
Neurodegenerative Diseases
Blood Glucose
Molecular Weight
Membranes

All Science Journal Classification (ASJC) codes

  • Biophysics

Cite this

Hsu, Yi Hsuan ; Chen, Yun-Wen ; Wu, Meng Hsin ; Tu, Ling Hsien. / Protein Glycation by Glyoxal Promotes Amyloid Formation by Islet Amyloid Polypeptide. In: Biophysical Journal. 2019 ; Vol. 116, No. 12. pp. 2304-2313.
@article{66b272308a0a40cca7d9b5448948f9e2,
title = "Protein Glycation by Glyoxal Promotes Amyloid Formation by Islet Amyloid Polypeptide",
abstract = "Protein glycation, also known as nonenzymatic glycosylation, is a spontaneous post-translational modification that would change the structure and stability of proteins or hormone peptides. Recent studies have indicated that glycation plays a role in type 2 diabetes (T2D) and neurodegenerative diseases. Over the last two decades, many types of advanced glycation end products (AGEs), formed through the reactions of an amino group of proteins with reducing sugars, have been identified and detected in vivo. However, the effect of glycation on protein aggregation has not been fully investigated. In this study, we aim to elucidate the impact of protein glycation on islet amyloid polypeptide (IAPP, also known as amylin) aggregation, which was strongly associated with T2D. We chemically synthesized glycated IAPP (AGE-IAPP) to mimic the consequence of this hormone peptide in a hyperglycemia (high blood sugar) environment. Our data revealed that AGE-IAPP formed amyloid faster than normal IAPP, and higher-molecular-weight AGE-IAPP oligomers were also observed in the early stage of aggregation. Circular dichroism spectra also indicated that AGE-IAPP exhibited faster conformational changes from random coil to its β-sheet fibrillar states. Moreover, AGE-IAPP can induce normal IAPP to expedite its aggregation process, and its fibrils can also act as templates to promote IAPP aggregation. AGE-IAPP, like normal IAPP, is capable of interacting with synthetic membranes and also exhibits cytotoxicity. Our studies demonstrated that glycation modification of IAPP promotes the amyloidogenic properties of IAPP, and it may play a role in accumulating additional amyloid during T2D progression.",
author = "Hsu, {Yi Hsuan} and Yun-Wen Chen and Wu, {Meng Hsin} and Tu, {Ling Hsien}",
year = "2019",
month = "6",
day = "18",
doi = "10.1016/j.bpj.2019.05.013",
language = "English",
volume = "116",
pages = "2304--2313",
journal = "Biophysical Journal",
issn = "0006-3495",
publisher = "Biophysical Society",
number = "12",

}

Protein Glycation by Glyoxal Promotes Amyloid Formation by Islet Amyloid Polypeptide. / Hsu, Yi Hsuan; Chen, Yun-Wen; Wu, Meng Hsin; Tu, Ling Hsien.

In: Biophysical Journal, Vol. 116, No. 12, 18.06.2019, p. 2304-2313.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Protein Glycation by Glyoxal Promotes Amyloid Formation by Islet Amyloid Polypeptide

AU - Hsu, Yi Hsuan

AU - Chen, Yun-Wen

AU - Wu, Meng Hsin

AU - Tu, Ling Hsien

PY - 2019/6/18

Y1 - 2019/6/18

N2 - Protein glycation, also known as nonenzymatic glycosylation, is a spontaneous post-translational modification that would change the structure and stability of proteins or hormone peptides. Recent studies have indicated that glycation plays a role in type 2 diabetes (T2D) and neurodegenerative diseases. Over the last two decades, many types of advanced glycation end products (AGEs), formed through the reactions of an amino group of proteins with reducing sugars, have been identified and detected in vivo. However, the effect of glycation on protein aggregation has not been fully investigated. In this study, we aim to elucidate the impact of protein glycation on islet amyloid polypeptide (IAPP, also known as amylin) aggregation, which was strongly associated with T2D. We chemically synthesized glycated IAPP (AGE-IAPP) to mimic the consequence of this hormone peptide in a hyperglycemia (high blood sugar) environment. Our data revealed that AGE-IAPP formed amyloid faster than normal IAPP, and higher-molecular-weight AGE-IAPP oligomers were also observed in the early stage of aggregation. Circular dichroism spectra also indicated that AGE-IAPP exhibited faster conformational changes from random coil to its β-sheet fibrillar states. Moreover, AGE-IAPP can induce normal IAPP to expedite its aggregation process, and its fibrils can also act as templates to promote IAPP aggregation. AGE-IAPP, like normal IAPP, is capable of interacting with synthetic membranes and also exhibits cytotoxicity. Our studies demonstrated that glycation modification of IAPP promotes the amyloidogenic properties of IAPP, and it may play a role in accumulating additional amyloid during T2D progression.

AB - Protein glycation, also known as nonenzymatic glycosylation, is a spontaneous post-translational modification that would change the structure and stability of proteins or hormone peptides. Recent studies have indicated that glycation plays a role in type 2 diabetes (T2D) and neurodegenerative diseases. Over the last two decades, many types of advanced glycation end products (AGEs), formed through the reactions of an amino group of proteins with reducing sugars, have been identified and detected in vivo. However, the effect of glycation on protein aggregation has not been fully investigated. In this study, we aim to elucidate the impact of protein glycation on islet amyloid polypeptide (IAPP, also known as amylin) aggregation, which was strongly associated with T2D. We chemically synthesized glycated IAPP (AGE-IAPP) to mimic the consequence of this hormone peptide in a hyperglycemia (high blood sugar) environment. Our data revealed that AGE-IAPP formed amyloid faster than normal IAPP, and higher-molecular-weight AGE-IAPP oligomers were also observed in the early stage of aggregation. Circular dichroism spectra also indicated that AGE-IAPP exhibited faster conformational changes from random coil to its β-sheet fibrillar states. Moreover, AGE-IAPP can induce normal IAPP to expedite its aggregation process, and its fibrils can also act as templates to promote IAPP aggregation. AGE-IAPP, like normal IAPP, is capable of interacting with synthetic membranes and also exhibits cytotoxicity. Our studies demonstrated that glycation modification of IAPP promotes the amyloidogenic properties of IAPP, and it may play a role in accumulating additional amyloid during T2D progression.

UR - http://www.scopus.com/inward/record.url?scp=85066268793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066268793&partnerID=8YFLogxK

U2 - 10.1016/j.bpj.2019.05.013

DO - 10.1016/j.bpj.2019.05.013

M3 - Article

VL - 116

SP - 2304

EP - 2313

JO - Biophysical Journal

JF - Biophysical Journal

SN - 0006-3495

IS - 12

ER -